262 related articles for article (PubMed ID: 10768993)
1. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis.
Freidag BL; Melton GB; Collins F; Klinman DM; Cheever A; Stobie L; Suen W; Seder RA
Infect Immun; 2000 May; 68(5):2948-53. PubMed ID: 10768993
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.
da Fonseca DM; Silva CL; Wowk PF; Paula MO; Ramos SG; Horn C; Marchal G; Bonato VL
Infect Immun; 2009 Dec; 77(12):5311-21. PubMed ID: 19752029
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.
Wedlock DN; Denis M; Skinner MA; Koach J; de Lisle GW; Vordermeier HM; Hewinson RG; van Drunen Littel-van den Hurk S; Babiuk LA; Hecker R; Buddle BM
Infect Immun; 2005 Jun; 73(6):3540-6. PubMed ID: 15908383
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.
Wedlock DN; Skinner MA; de Lisle GW; Vordermeier HM; Hewinson RG; Hecker R; van Drunen Littel-van den Hurk S; Babiuk LA; Buddle BM
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):53-63. PubMed ID: 15910992
[TBL] [Abstract][Full Text] [Related]
5. Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice.
Freches D; Romano M; Korf H; Renauld JC; Van Snick J; Uyttenhove C; Huygen K
Clin Vaccine Immunol; 2011 Jan; 18(1):95-104. PubMed ID: 21084465
[TBL] [Abstract][Full Text] [Related]
6. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
7. Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.
Pitt JM; Stavropoulos E; Redford PS; Beebe AM; Bancroft GJ; Young DB; O'Garra A
J Immunol; 2012 Oct; 189(8):4079-87. PubMed ID: 22972927
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype.
Rao V; Dhar N; Shakila H; Singh R; Khera A; Jain R; Naseema M; Paramasivan CN; Narayanan PR; Ramanathan VD; Tyagi AK
Scand J Immunol; 2005 May; 61(5):410-7. PubMed ID: 15882432
[TBL] [Abstract][Full Text] [Related]
9. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.
Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ
Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of CpG oligodeoxynucleotide fails to enhance the protective efficacy of a subunit vaccine against Mycobacterium tuberculosis.
Hsieh MJ; Junqueira-Kipnis AP; Hoeffer A; Turner OC; Orme IM
Vaccine; 2004 Jan; 22(5-6):655-9. PubMed ID: 14741157
[TBL] [Abstract][Full Text] [Related]
11. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
12. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
Hwang SA; Kruzel ML; Actor JK
Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.
Cafaro A; Piccaro G; Altavilla G; Gigantino V; Matarese G; Olivieri E; Ferrantelli F; Ensoli B; Palma C
BMC Infect Dis; 2016 Aug; 16(1):442. PubMed ID: 27549342
[TBL] [Abstract][Full Text] [Related]
16. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
[TBL] [Abstract][Full Text] [Related]
19. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
20. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice.
Li W; Huang H; Hua W; Ben S; Liu H; Xu B; Xian Q; Tang Z; Shen H
Vaccine; 2012 May; 30(21):3223-30. PubMed ID: 22342709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
